The latest breakthrough for GLP-1 drugs isn’t scientific. It’s financial.
As of July 1, Medicare is providing coverage of GLP-1 medications for weight loss for just a $50 co-pay, potentially enabling millions more Americans to get onto this much-hyped new class of drugs. Medicare’s GLP-1 Bridge Program, as it is called, is technically a one-year pilot project authorized by the Trump administration. Medicare previously limited GLP-1 coverage to people who have diabetes, heart disease, or obstructive sleep apnea.
Under the new program, Medicare enrollees will be eligible to receive o...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free